NeoClone's Angel - II Round

NeoClone raised a round of funding on January 12, 2013. Investors include Wisconsin Investment Partners.

NeoClone is a custom monoclonal antibody company focused on developing high quality antibodies for sale as reagents and establishing partnerships and collaborations to develop diagnostic mAbs.…

Articles about NeoClone's Angel - II Round: